Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

These three weeds have important medicinal properties and need more research for potential pharmaceutical use.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

A family got a fungal infection from a boy who had contact with rabbits, but they all recovered with treatment.

Modified stem cells from umbilical cord blood can make hair grow faster.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Hydroxychloroquine may help treat alopecia areata in children.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Minoxidil may help hair growth by stopping immune system attacks on hair follicles.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Effective treatments for severe alopecia areata are still lacking.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

PRP and cell therapies may help with hair loss, but more research is needed.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Ketoconazole shampoo is a safe and effective treatment for scalp seborrheic dermatitis.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.